SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing significant selling pressure as investors digest a string of unfavorable legal verdicts and ongoing concerns regarding AI-related capital expenditures and layoffs. Community discussions are split between those viewing the pullback as a prime dip-buying opportunity given the company's strong cash flow and those expressing deep skepticism, with many traders actively debating the impact of increasing legal scrutiny and long-term business model viability.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is experiencing significant volatility as investors debate the impact of a recent short-seller report and ongoing geopolitical tensions on the stock's growth trajectory. While some community members express frustration over recent price declines and dilution concerns, bullish investors remain focused on the company's long-term potential, citing strong fundamentals, the expansion of its Galileo platform, and continued institutional support as key reasons to maintain their positions.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is facing significant downward pressure as market participants weigh broader macro volatility and sector-wide weakness against the company's high growth potential and new AI data partnerships. While some investors are actively accumulating shares based on improving fundamentals and recent insider activity, others are heavily shorting the stock, citing concerns over potential bot-driven metrics and the platform's long-term monetization sustainability.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as investors react to a combination of geopolitical uncertainty and concerns that Googles new memory compression technology might dampen long-term demand for high-bandwidth chips. While some in the community see the sharp pullback as an irrational overreaction and a buying opportunity given the company's strong earnings fundamentals, others are bracing for further volatility, debating whether current price levels signal a bottom or a deeper correction for the broader semiconductor sector.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

Market participants are actively debating the potential for an aggressive market correction, driven by fears surrounding the ongoing Middle East conflict and its impact on oil prices, supply chain logistics, and global liquidity. Sentiment remains highly volatile as traders react to conflicting rhetoric from leadership regarding ceasefire negotiations, with many adopting defensive strategies or bearish positions while awaiting further catalysts.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is currently trending as investors weigh strong CPU demand and pricing power against broader geopolitical risks and market volatility. The community remains divided, with some traders focusing on technical gap fills and tactical scalping, while others argue over the stock's long-term potential versus concerns regarding its sensitivity to global supply chain disruptions.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is trending due to a significant private placement and investor excitement surrounding its INHBE-targeting obesity drug, WVE-007, which is being touted for its potential to drive 'quality' weight loss through visceral fat reduction and muscle preservation. While some community members are bullish on the company's platform and long-term outlook, others are expressing caution regarding recent insider selling and the volatility typical of early-stage biotech trials.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is currently experiencing extreme volatility and intense community frustration following a reverse stock split, with investors aggressively debating whether the move is a setup for a potential short squeeze or a terminal decline. The conversation is dominated by allegations of management silence and mismanagement, while retail traders remain sharply divided between those calling for a mass exit and those holding out for a miraculous turnaround fueled by institutional interest.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing extreme volatility as investors grapple with escalating geopolitical tensions and a sharp surge in oil prices, prompting intense community debate over whether to "buy the dip" or brace for a deeper structural decline. While some traders view current price levels as a discounted opportunity to accumulate shares ahead of expected AI sector growth, others are warning of significant downside risks, citing the fund's inherent decay and the broader macro uncertainty surrounding the conflict.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak Sciences is trending following the announcement of positive topline results in its GLOW2 Phase 3 study, where the drug Zenkuda demonstrated superiority over a sham treatment in patients with diabetic retinopathy. The stock has experienced significant volatility and a strong rally as investors react to the trial's best-in-class safety profile and accelerated regulatory plans, fueling active community discussions regarding a potential short squeeze and the company's long-term commercial potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 9% - Time to Buy?

Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 9% Higher - Should You Buy...

Alexander Denner Sells 6,730,800 Shares of Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) Director Alexander Denner sold 6,730,800 shares of the business's stock in a transaction on Tuesday, March 17th. The shares were sold at...

Insider Selling: Ironwood Pharmaceuticals (NASDAQ:IRWD) Director Sells 6,730,800 Shares of Stock

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) Director Alexander Denner sold 6,730,800 shares of the stock in a transaction that occurred on Tuesday, March 17th. The shares were sold...

Ironwood Pharmaceuticals (NASDAQ:IRWD) Sees Strong Trading Volume - Should You Buy?

Ironwood Pharmaceuticals (NASDAQ:IRWD) Sees Large Volume Increase - Should You Buy...

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Short Interest Up 15.8% in February

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) saw a significant growth in short interest in February. As of February 27th, there was short interest totaling 12,917,285 shares, a...

IRWD vs. PBYI: Which Small-Cap Biotech Stock Is a Better Buy?

Ironwood and Puma Biotechnology are developing GI and cancer therapies, respectively, with sales of their sole drugs expected to support 2026 revenues.

Ironwood Pharmaceuticals (NASDAQ:IRWD) Rating Lowered to "Buy" at Wall Street Zen

Wall Street Zen cut Ironwood Pharmaceuticals from a "strong-buy" rating to a "buy" rating in a report on Saturday...

Will Linzess Continue to Aid IRWD's Top Line in 2026 After a Soft Q4?

Ironwood sees Linzess rebounding in 2026 despite soft Q4 results, helped by strong prescription demand and improved net pricing.

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that management will participate in a fireside chat at The Citizens Life Sciences Conference on Wednesday, March 11th at 4:00 p.m. ET. A...

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Consensus Recommendation of "Hold" from Brokerages

Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) have been given an average recommendation of "Hold" by the eight ratings firms that are currently covering the company...

Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.

Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

ManoJaggarwal bullish call on $MU at $68.07

FinnessaurusFlex bullish call on $ASTS at $1.98

NeverFadeTheOracle bullish call on $SNDK at $41.95

stockwinner1966 bullish call on $USAS at $0.42

Celebrating the single best "called shot" of the year. This award honors a trade that combined timing with conviction, proving that market mastery is an art.

IRWD
Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest IRWD News

IRWDIronwood Pharmaceuticals Inc - Ordinary Shares - Class A